Gender-based differences in pediatric nuclear medicine

Adina L Alazraki1, Kiery A Braithwaite1

  • 1Department of Radiology and Imaging Sciences, Children's Healthcare of Atlanta, Emory University, Atlanta, GA.

Insights

Pediatric nuclear medicine interpretation requires considering age and gender. Recognizing these factors is crucial for accurate diagnosis in pediatric patients.

Area of Science:

  • Pediatric Nuclear Medicine
  • Radiology
  • Medical Imaging

Background:

  • Gender-based physiological differences are present from infancy and evolve through puberty in pediatric patients.
  • Nuclear medicine protocols for adults are often adapted for pediatric imaging.
  • Interpreting pediatric studies necessitates awareness of age and gender-specific norms.

Purpose of the Study:

  • To highlight the importance of age and gender in pediatric nuclear medicine.
  • To emphasize the need for physicians to understand developmental changes in relation to imaging findings.
  • To underscore the significance of these factors in diagnosing pediatric conditions.

Main Methods:

  • Review of established pediatric nuclear medicine principles.
  • Analysis of how gender and age influence physiological parameters relevant to imaging.
  • Comparison of pediatric and adult imaging protocols and their adaptations.

Main Results:

  • Age and gender significantly impact normal physiological variations seen in pediatric nuclear medicine scans.
  • Underrecognition of age-defined, gender-based subtleties can occur.
  • These factors are important in evaluating both benign and pathological processes.

Conclusions:

  • Accurate interpretation of pediatric nuclear medicine studies mandates consideration of the patient's age and gender.
  • Familiarity with evolving physiological changes specific to developmental stages is essential.
  • Incorporating age and gender knowledge improves diagnostic accuracy and clinical workup in pediatric patients.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
532
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
918
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
972
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
391
Radiological Investigation I: X-ray and CT01:30

Radiological Investigation I: X-ray and CT

Radiological investigations, including X-rays and computed tomography (CT) scans, are critical for diagnosing and evaluating various medical conditions. These imaging techniques provide valuable insights into the body's internal structures, aiding in the detection of abnormalities, assessment of disease progression, and development of treatment strategies. This article delves into two primary radiological investigations, chest X-rays and CT scans, outlining their purpose, procedures, and...
1.7K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
825